General MedicationsORALGeneric
DIDANOSINE
DIDANOSINE
Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview DIDANOSINE is listed in Drugs@FDA under application 090788 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DIDANOSINE Form and strength CAPSULE, DELAYED REL PELLETS;ORAL - 200MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2019-12-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview DIDANOSINE is listed in Drugs@FDA under application 090788 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DIDANOSINE Form and strength CAPSULE, DELAYED REL PELLETS;ORAL - 200MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2019-12-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.